• Veratridine: Practical Sodium Channel Assays

  2026-09-02

  Veratridine provides a controllable depolarization trigger for sodium channel dynamics research, excitotoxicity studies, and blocker screening. This workflow-centered guide explains how to separate sodium-channel effects from downstream glutamate and calcium signaling while extending the compound cautiously into UBXN2A-focused oncology research.

• Sulfo-Cy3 NHS Ester for Reliable Cell Assays

  2026-09-02

  This scenario-driven guide explains how Sulfo-Cy3 NHS ester, SKU A8107, can improve the interpretability of protein-labeling workflows used alongside cell viability, proliferation, and cytotoxicity assays. It covers aqueous handling, spectral controls, protocol optimization, data interpretation, and practical vendor-selection criteria.

• Sealable Nanovials for High-Throughput Cell Screening

  2026-09-01

  The reference preprint introduces capped nanovials, suspendable hydrogel compartments formed by docking bowl-shaped nanovials with spherical capping particles. The platform supports single-cell and co-culture assays, growth and secretion measurements, fluorescence imaging, flow cytometry, and selection using standard pipetting and centrifugation workflows.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-09-01

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidic, clathrin-mediated pathway. The lack of inhibition by Latrunculin B distinguishes this entry route from pathways requiring measurable actin polymerization, while also illustrating the limits of interpreting single-inhibitor results as universal rules for viral uptake.

• Antiarrhythmic Drugs and KCa2 Channels in AF

  2026-08-31

  This 2017 study used automated whole-cell patch clamp to test whether antiarrhythmic drugs for atrial fibrillation directly inhibit human KCa2.2 and KCa2.3 channels. Dofetilide and propafenone showed inhibition, whereas Dronedarone was not among the active compounds, indicating that KCa2 channel modulation is unlikely to explain the principal clinical actions of most tested drugs at therapeutic exposure.

• Axitinib (AG 013736): From Mechanism to Translation

  2026-08-31

  A mechanism-first guide to using Axitinib (AG 013736) in angiogenesis inhibition assays, VEGF signaling pathway modulation, and tumor xenograft studies—while improving the translational value of cancer biology research.

• Kif9 and Centriolar Satellite Positioning

  2026-08-30

  Vicente et al. identify the kinesin Kif9 as a spatial regulator of centriolar satellites during interphase, linking satellite position to centrosomal proteostasis and mitotic fidelity. The study provides a mechanistic framework for understanding how premitotic centrosome organization influences spindle formation and chromosome segregation.

• Beyond Viability: Measuring Drug Response in Cancer

  2026-08-29

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their different proportions and time courses in vitro.

• Miltefosine Activates ERK in Neutrophil Differentiation

  2026-08-28

  The reference study identifies Miltefosine as an experimental strategy for leukopenia by showing that it promotes neutrophil differentiation through Ras/MEK/ERK pathway activation. Integrated cell, mouse, transcriptomic, network-pharmacology, docking, and inhibitor experiments connect this response to improved neutrophil function and recovery of irradiated bone marrow.

• Resazurin Cell Viability Assay Kit in Redox Oncology

  2026-08-28

  Discover how the Resazurin Cell Viability Assay Kit can quantify drug responses while revealing important redox-related interpretation limits. Using parthenolide-treated lymphoid malignancy cells as a model, this guide connects assay chemistry with apoptosis validation and experimental design.

• Cy7 NHS Ester (A8109): Practical Labeling Guide

  2026-08-27

  Cy7 NHS ester is a water-compatible near-infrared dye for bioimaging that supports amino-group labeling of proteins, peptides, and other biomolecules. It is useful when organic cosolvents may compromise a delicate sample, but freshly prepared solutions should be used promptly rather than stored long term.

• RIPA Lysis Buffer (Strong): Reliable Cell Assays

  2026-08-27

  Learn how RIPA Lysis Buffer (Strong), SKU K1020, supports reproducible protein extraction after viability, proliferation, and cytotoxicity assays. This scenario-based guide connects formulation, sample handling, assay compatibility, and vendor-selection decisions to practical laboratory workflows.

• 5-Methyl-CTP for Modified mRNA Synthesis

  2026-08-26

  5-Methyl-CTP is a 5-methyl modified cytidine triphosphate used as a substrate for in vitro transcription of modified mRNA. Its product specifications support controlled reagent handling, while published RNA-modification literature indicates that biological effects depend on transcript design, incorporation, purification, and delivery context.

• Recombinant Human Oncostatin M: Assay Guide

  2026-08-26

  Learn how Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized), SKU P1045, can address variability in viability, proliferation, and cytokine-release assays. This scenario-based guide covers assay interpretation, reconstitution, controls, cross-model comparisons, and practical vendor-selection criteria.

• Tetrahydromagnolol for CB2 Signaling Workflows

  2026-08-25

  Tetrahydromagnolol combines potent peripheral CB2 agonism with GPR55 antagonism, enabling pathway-resolved cannabinoid receptor research rather than single-endpoint screening. This guide translates those properties into receptor, inflammatory, migration, and GPCR-to-cytoskeleton workflows while clearly separating established evidence from testable applications.

554 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page